Events & Trainings

Current meetings, workshops, education

Academic Events

As a specialist scientific organisation, we hold many challenging events every year.

In a two-year cycle, the AGAH holds an acclaimed scientific congress in Germany, where relevant topics that interest our members are discussed – alternating with a scientific event with one of our partner organisations, AHPPI in UK, Bapu in Belgium or Association Française de Pharmacologie Translationelle (AFPT) -Le Club Phase I in France.

In addition, scientific workshops are held on special topics and there is a yearly national discussion round together with the BfArM, where mostly safety-relevant matters in early-phase clinical studies are discussed. The programme is rounded off with training courses, entitled Introductory or Applied Workshops for young scientists and a training programme specifically for study nurses.

  • DETAILS

    28th Pharmacokinetics/Pharmacodynamics (PK/PD) Expert Meeting

    Leonardo Weimar  |  Apr 23 - Apr 25, 2026

    This meeting will take place at Hotel Leonardo Weimar under the auspices of AGAH (Arbeitsgemeinschaft für Angewandte Humanpharmakologie e. V.) and starts with a joint Dinner on 23 April 2026. The scientific programme begins on Friday morning, 24 April 2026 and ends on Saturday, 25 April 2026 at lunchtime.

  • DETAILS

    AGAH Workshop: Toxic Truths and Dosing Dilemmas

    SocraTec R&D Oberursel  |  May 7 - May 8, 2026  |  13:00 – 13:00

    Navigating Early Drug Development – Translational Aspects of CNS Safety Findings

  • DETAILS

    AGAH Mebinar | Patients in Phase I - The earlier the better?

    Digital Event  |  May 20 - May 20, 2026  |  17:30 – 19:00

    - Making the right population choice in first-in-human and early development trials

  • DETAILS

    AGAH Mebinar | Applied Pharmacovigilance in Clinical Trials

    Digital Event  |  Jul 8 - Jul 8, 2026  |  17:30 – 19:00

    – Inspection-Ready in Practice

  • DETAILS

    AGAH Mebinar | From Pawlow to Patients

    Digital Event  |  Sep 30 - Sep 30, 2026  |  17:30 – 19:00

    – A Cross Species Exploration of Placebo Effects

  • DETAILS

    AGAH Mebinar | Electronic Health Records (EHR)

    Digital Event  |  Nov 4 - Nov 4, 2026  |  17:30 – 19:00

    - routine clinical data that are created every day in hospitals, allow “secondary use” that can dramatically improve patient identification and recruitment—faster feasibility checks

  • DETAILS

    EPHAR 2027

    Partner-Event  |  Goethe-Universität Frankfurt  |  Mar 9 - Mar 11, 2027

    The Federation of European Pharmacological Societies

  • DETAILS

    AGAH Applied Course | Introduction into basic principles of clinical pharmacokinetics

    SocraTec R&D Oberursel  |  Oct 13 - Oct 14, 2026  |  08:00 – 16:00
  • DETAILS

    Introductory Course in Exploratory Medicines Development – Part I online (6 half-days)

    Digital Event  |  Oct 21 - Nov 5, 2026

    This course addresses postgraduates in life sciences interested in early clinical development of medicinal products. Two training parts of several days provide a concise overview on Human Pharmacology / Translational Medicine spanning from non-clinical pharmacology and toxicology over first-in-man studies to proof-of-concept clinical trials.

  • DETAILS

    Introductory Course in Exploratory Medicines Development – Part II face2face

     |  Nov 24 - Nov 27, 2026

    This course addresses postgraduates in life sciences interested in early clinical development of medicinal products. Two training parts of several days provide a concise overview on Human Pharmacology / Translational Medicine spanning from non-clinical pharmacology and toxicology over first-in-man studies to proof-of-concept clinical trials.

AGAH e.V.
28th Pharmacokinetics/Pharmacodynamics (PK/PD) Expert Meeting

This meeting will take place at Hotel Leonardo Weimar under the auspices of AGAH (Arbeitsgemeinschaft für Angewandte Humanpharmakologie e. V.) and starts with a joint Dinner on 23 April 2026. The scientific programme begins on Friday morning, 24 April 2026 and ends on Saturday, 25 April 2026 at lunchtime.

Apr 23 - Apr 25, 2026
Program Information

Preliminary Programme Download:


Download 2026_Agenda_PKPD_2026.pdf
Registration Information

Start you registration from 15 November 2025 - Book your seat in time - number of participants is limited.

The conference fee includes also the accommodation costs, further information is available within the registration.


PLEASE START YOUR

Online Registration
Awards

Young scientists: Hans Günter Schäfer Award
Generous donations have enabled the Organizing Committee of the PK/PD Expert Meeting to reward outstanding contributions to the PK/PD field by young scientists with the Hans Günter Schäfer Award (cash amount of 1.000 EUR plus free meeting participation incl. travel expenses) issued in memory of the original initiator of the PK/PD Expert Meeting. The award is kindly sponsored by the Frankfurt Foundation Quality of Medicines.
If you are a Doctorate student or young scientist (less than two years after PhD degree) and want to apply for this award, send your peer-reviewed, published manuscript as a pdf file to Tobias Pähler - tobias.paehler[@]sanofi.com. Manuscript submissions must be accompanied by a brief description (500 words maximum) of how your manuscript fits into the overall scientific context of the respective research area, with a specific focus on its innovation, methodology and clinical or in vivo relevance. Submission deadline: 1 February 2026; applicant notification by 10 March 2026. The winner will be announced on the website of the PK/PD Expert Meeting and will present their work as part of the main conference.

Master / Doctorate students: Best presentation award
Three young PK/PD scientists will be given the opportunity to give an oral presentation of their work (5 minutes) as part of the main conference. All invited presenters will participate free of charge (incl. accommodation). The best presenter will be honored and will receive the “Young Scientist Best Presentation Award” plus reimbursement of travel expenses.
If you are a Master thesis or Doctorate student and want to apply for this award, send an abstract (500 words maximum) to Tobias Pähler - tobias.paehler[@]sanofi.com.
Submission deadline: 1 February 2026; applicant notification by 10 March 2026.
Three applicants will be selected and invited for presentation.

Application to both awards is possible. However, expectation is that a dedicated abstract is written for the ‘Best presentation award’, submission of one complete manuscript for both categories will not be accepted.


General Terms of Registration

General-Terms-of-Registration_AGAH_PK_PD_Expertmeeting2026.pdf
Event Location
Leonardo Weimar
Belvederer Allee 25,
99425 Weimar
www.leonardo-hotels.com
Event Manager
CSi Hamburg GmbH
+49 40 30770300
agah-meetings@csihamburg.de
https://csihamburg.de
AGAH Workshop: Toxic Truths and Dosing Dilemmas

Navigating Early Drug Development – Translational Aspects of CNS Safety Findings

May 7 - May 8, 2026  |  13:00 – 13:00
Program Information

AGAH Workshop on the Early Safety Assessment of Drugs

with a Focus on CNS Safety Findings – Concepts, Strategies, and Potential Pitfalls.

Developing drugs with CNS-related safety concerns poses distinct challenges. Robust strategies are essential to identify, characterize, and mitigate risks early in clinical development. This AGAH workshop offers a deep dive into translational aspects, risk management strategies, and real-world lessons - including insights that shaped the 2018 revision of the EMA first-in-human guideline, designed to critically evaluate and refine decision-making in early-phase trials. 


Key questions we will explore together:

1.    Which early safety assessment results are most robust from a translational perspective?

2.    What strategies best support human risk/benefit evaluation in drug development?

3.    How have regulatory guidelines evolved to strengthen risk mitigation in first-in-human studies?


Real-world case studies – including both discontinued compounds (e.g., BIA 10-2474) and approved drugs – will illustrate these key questions. While the focus is on CNS-active compounds, the principles and strategies explored in this workshop are broadly applicable across therapeutic areas.


Preliminary schedule

Thursday: 13:00–19:00
Friday: 8:30 –13:00

Download AGAH_Workshop_CNS_7-8_May_2026.pdf
Registration Information

Participation fee

750 € Regular
500 € Member* 
500 € Junior Scientist up to the age of 30
250 € Member of Regulatory Agencies or ethics committees

*of the following EUFEMED society: AGAH, AHPPI, AFPT - Le Club Phase 1, HEALIXIA, POLFEMED

START YOUR:

Online Registration
GENERAL TERMS AND CONDITIONS OF REGISTRATION
General-Terms-of-Registration_AGAH_WS_Toxic_Truths_Dosing_Dilemmas_2026.pdf
Event Location
SocraTec R&D Oberursel
Im Setzling 35,
61440 Oberursel
https://socratec-pharma.de/
Event Manager
CSi Hamburg GmbH
+49 40 30770300
agah-meetings@csihamburg.de
https://csihamburg.de
AGAH Mebinar | Patients in Phase I - The earlier the better?

- Making the right population choice in first-in-human and early development trials

May 20 - May 20, 2026  |  17:30 – 19:00
-To be held in English-

Including patients already in first-in-human trials is often seen as the fastest route to clinically relevant insights—but is it always the best choice? What do current guidelines and regulatory expectations actually say about including (or excluding) patients in early development, and how much of the perceived “trend” toward earlier patient inclusion is real versus anecdotal?
In this AGAH member webinar, we’ll explore the key trade-offs between rapid pharmacologic learning in healthy volunteers and earlier, potentially more relevant clinical signals in patients—while also addressing practical implications such as eligibility criteria, safety margins, interpretability of endpoints, operational complexity, and decision-making speed. We’ll conclude with a pragmatic toolbox: core aspects and questions to consider to select the most suitable population and design for the trial at hand.


Speaker and in Dialogue with

Dr rer. nat. Robert Schultz-Heienbrok, Charité Research Organisation

Burkhard Kerlin, Bayer AG


Please feel free to submit your questions in advance by 15 May 2026 via the registration form.

Download Programme_AGAH_Mebinar_20-05-2026.pdf
Registration Information

AGAH Member - 0 EUR
Guest - 40 EUR

Registrations welcome until 18 May 2026 (= access details will be sent)

Online Registration
Additional Information
AGAH_Mebinar_Terms_of_Registration.pdf
FAQ_AGAH_Mebinar.pdf
Event Manager
CSi Hamburg GmbH
+49 40 30770300
agah-meetings@csihamburg.de
https://csihamburg.de
AGAH Mebinar | Applied Pharmacovigilance in Clinical Trials

– Inspection-Ready in Practice

Jul 8 - Jul 8, 2026  |  17:30 – 19:00
-To be held in English-

When you conduct clinical research, it’s a regulatory requirement to be familiar with—and correctly apply—core pharmacovigilance rules and processes. In this practical webinar, we explain the pharmacovigilance duties during the conduct of clinical trials and how to set up compliance end-to-end. 

You’ll learn how to address key regulatory expectations and deliverables, including CIOMS form, EudraVigilance/EVWEB, ICH E2B, ICH E2F, ICH E3, and spontaneous reporting. We’ll also cover critical reccuring trial safety responsibilities such as DSUR, medical literature monitoring, and essential oversight roles including the QPPV and the German Stufenplanbeauftragter. 

Beyond the theory, we’ll walk through an inspection-focused toolkit needed when setting up a clinical trial: Safety Management & Communication Plans, SAE/AE intake and SAE forms, follow-up workflows, reconciliation touchpoints, escalation pathways, and safety governance—including how protocol-defined pausing/stopping rules are handled in practice. 


Speaker and in Dialogue with
Caroline Matthey, SocraMetrics GmbH
Dr Ruwen Böhm, SocraTec R&D


Please feel free to submit your questions in advance by 3 July 2026 via the registration form.

Download Programme_AGAH_Mebinar_08-07-2026.pdf
Registration Information

AGAH Member - 0 EUR
Guest - 40 EUR

Registrations welcome until 06 July 2026 (= access details will be sent)

Online Registration
Additional Information
AGAH_Mebinar_Terms_of_Registration.pdf
FAQ_AGAH_Mebinar.pdf
Event Manager
CSi Hamburg GmbH
+49 40 30770300
agah-meetings@csihamburg.de
https://csihamburg.de
AGAH Mebinar | From Pawlow to Patients

– A Cross Species Exploration of Placebo Effects

Sep 30 - Sep 30, 2026  |  17:30 – 19:00
-To be held in English-

How placebo effects manifest in animals and humans, and what this means for controlling bias in toxicology studies and clinical research

Speaker and in Dialogue with

Dr Stephanie Plassmann, PCS – The Integrated Drug Development Company
Board Certified Specialist in Veterinary Pharmacology and Toxicology
Senior Expert in Non-Clinical Drug Development

Dr Martin Coenen, Universitätsklinikum Bonn
Medical Director, Phase I Unit / Senior Physician, Clinical Pharmacology (Outpatient Clinic and Consultation Service) / Deputy Managing Director


Please feel free to submit your questions in advance by 25 September 2026 via the registration form.

Download Programme_AGAH_Mebinar_30-09-2026.pdf
Registration Information

AGAH Member - 0 EUR
Guest - 40 EUR

Registrations welcome until 28 September 2026 (= access details will be sent)

Online Registration
Additional Information
AGAH_Mebinar_Terms_of_Registration.pdf
FAQ_AGAH_Mebinar.pdf
Event Manager
CSi Hamburg GmbH
+49 40 30770300
agah-meetings@csihamburg.de
https://csihamburg.de
AGAH Mebinar | Electronic Health Records (EHR)

- routine clinical data that are created every day in hospitals, allow “secondary use” that can dramatically improve patient identification and recruitment—faster feasibility checks

Nov 4 - Nov 4, 2026  |  17:30 – 19:00
Program Information

faster feasibility checks, better site selection, and more realistic recruitment planning. 

In this AGAH webinar, we’ll discuss how to leverage EHR across key systems (HIS, CDSS, LIMS, PACS), and why real-world implementation still hinges on data structure and interoperability: from “PDF scans” and annotation gaps to connectivity issues, data privacy challenges, and mapping between code systems. Intentional miscoding occuring in current clinical practice for various reasons will be explained. We’ll also cover the role (and pitfalls) of clinical coding and standards (ICD, SNOMED CT, OPS, LOINC/UCUM, ATC), and introduce current approaches such as Medical Informatics Initiative (MII), FHIR, querying FHIR servers, and real-world data networks like TriNetX—ending with practical ways to assess recruitment potential and estimate recruitment rates based on hospital admissions. 

Speaker and in Dialogue with
Mehmet Akyuz, Healthcare Partnership Manager
Dr Ruwen Böhm, SocraTec R&D


Please feel free to submit your questions in advance by  30 October 2026 via the registration form.

Download Programme_AGAH_Mebinar_04-11-2026.pdf
Registration Information

AGAH Member - 0 EUR
Guest - 40 EUR

Registration welcome until 2 November 2026 (= dispatch of dial-in details)

Online Registration
Additional Information
AGAH_Mebinar_Terms_of_Registration.pdf
FAQ_AGAH_Mebinar.pdf
Event Manager
CSi Hamburg GmbH
+49 40 30770300
agah-meetings@csihamburg.de
https://csihamburg.de
EPHAR 2027

The Federation of European Pharmacological Societies

Mar 9 - Mar 11, 2027
Program Information

Congress Chair
Roland Seifert
Institute of Pharmacology I Hannover Medical School

Download EPHAR-2027_Ankuendigung.pdf
Registration Information
Online Registration
Event Location
Goethe-Universität Frankfurt
Campus Westend,
60323 Frankfurt am Main,
Germany
Event Manager
Conventus Congressmanagement & Marketing GmbH
https://portal.conventus.de/events/ephar-2027
AGAH Applied Course | Introduction into basic principles of clinical pharmacokinetics
Oct 13 - Oct 14, 2026  |  08:00 – 16:00
Program Information

Pharmacokinetics – prerequisite and at the same time “door opener” for understanding pharmacology!

This workshop, developed by experienced specialists from industry, CRO and consultancy, offers an entrée to physiological background, measures, and characteris-tics of pharmacokinetics. It helps to understand study design and evaluation of PK studies and the conclusions drawn from the results.
The workshop has been developed for clinical investiga-tors, project leaders, project managers and monitors as well as PhD students in industry, hospitals, university and CROs. The knowledge obtained in this applied in-troductory course helps beginners in pharmacokinetics obtaining the basic knowledge and scientific back-ground for professional handling, evaluation, and inter-pretation of PK data.


Download AGAH_Workshop_PK_13-14_Oct_2026.pdf
Registration Information

Accommodation is not included and must be arranged individually. Please feel free to book your room directly with the hotel using the room block below. The hotel is located nearby, about 900 meters away on foot.

elaya hotel frankfurt oberursel
Zimmersmühlenweg 35
61440 Oberursel

Room rate: 99 EUR per night for a single room
Booking deadline: 14/09/2026
Free cancellation until: 28/09/2026

Phone: +49 6171 500 604
Email: bookings.frankfurt-oberursel@elaya-hotels.com
Booking code: AGAH PK 2026


Start your registration (welcome until 27 September 2026). Minimum number of participants: 10.

Online Registration
GENERAL TERMS AND CONDITIONS OF REGISTRATION

Attendance Fee
950 € Regular
750 € Member of AGAH, EUFEMED
or Junior Scientist up to the age of 30

The participation fee is per person. Please note, according to §4 para 22 German turnover tax law, registration and work-shop fees are exempt from VAT. Registration fees are charged and collected on behalf of AGAH e. V. All bookings are subject to change.

General-Terms-of-Registration_AGAH_Applied_PK_WS_2026.pdf
Event Location
SocraTec R&D Oberursel
Im Setzling 35,
61440 Oberursel
https://socratec-pharma.de/
Event Manager
CSi Hamburg GmbH
+49 40 30770300
agah-meetings@csihamburg.de
https://csihamburg.de
Introductory Course in Exploratory Medicines Development – Part I online (6 half-days)

This course addresses postgraduates in life sciences interested in early clinical development of medicinal products. Two training parts of several days provide a concise overview on Human Pharmacology / Translational Medicine spanning from non-clinical pharmacology and toxicology over first-in-man studies to proof-of-concept clinical trials.

Oct 21 - Nov 5, 2026
Program Information

Learning Outcomes

On successful completion of Part 1, students should be able to demonstrate an understanding / knowledge of the following:

  • principal steps in drug development - from compound selection to marketing application and beyond
  • pertinent issues involved in the undertaking of early clinical research
  •  specific aspects of how to set-up and conduct early phase clinical trials
  •  regulation of medicines in Europe
  • development and review of compound-specific information to ensure adherence to scientific, medical, ethical, and legal provisions
  • integration of pertinent available scientific information into an IB and a clinical trial protocol
  • principles of trial design, protocol submission and clinical conduct
  • selection of appropriate trial population
  • most common early phase clinical trials and their specific requirements
  • assessment and evaluation of safety data from clinical trials
  • relevance of formulation properties and in vitro characteristics of the trial medication for design and planning of an early phase clinical trial
  • basics of pharmacokinetics
  • defining pharmacokinetic (PK) endpoints for early phase clinical trials
  • method validation according to good clinical (GCP) and good laboratory (GLP) practise practical aspects of bioequivalence trials
Download AGAH_Introductory2026_Programm_Part1.pdf
Download AGAH_Introductory2026_Programm_Part2.pdf
Registration Information

Fees Part I or Part II

1.700 EUR Member*
2.000 EUR Regular Guest

Part I and Part II

2.800 EUR Member*
3.200 EUR Regular Guest

*of AGAH, ACRON, AFPT-CPI, AHPPI, EUFEMED, Healixia, Polfemed

Special fees for students are available on request.

If a company registers four participants, the fifth place is free of charge.


Min. number of participants 10 guests.

Registration deadline Part I: 20 September 2026.

Accommodation (23–27/11/2026)
Accommodation is not included and must be arranged individually. Please feel free to book your room directly with the hotel using the room block below. The hotel is located nearby, about 900 meters away on foot.

elaya hotel frankfurt oberursel
Zimmersmühlenweg 35
61440 Oberursel

Room rate: 144 EUR per night for a single room, 164 EUR per night for a double room
Booking deadline: 26/10/2026
Free cancellation until: 09/11/2026

Phone: +49 6171 500 0
Email: bookings.frankfurt-oberursel@elaya-hotels.com
Booking code: AGAH Intro Kurs 2026



Start your registration:

Online Registration
Part I - Online

Day 1    21 October 2026 13:00–17:30

Day 2    22 October 2026 13:00–17:15

Day 3    28 October 2026 13:00–17:15

Day 4    29 October 2026 13:00–16:15

Day 5     4 November 2026 13:00–17:45

Day 6     5 November 2026 13:00–16:45

Mandatory test | 9 November 2026, 17:00-19:00

Event Manager
CSi Hamburg GmbH
+49 40 30770300
agah-meetings@csihamburg.de
https://csihamburg.de
Introductory Course in Exploratory Medicines Development – Part II face2face

This course addresses postgraduates in life sciences interested in early clinical development of medicinal products. Two training parts of several days provide a concise overview on Human Pharmacology / Translational Medicine spanning from non-clinical pharmacology and toxicology over first-in-man studies to proof-of-concept clinical trials.

Nov 24 - Nov 27, 2026
Program Information

Learning Outcomes

On successful completion of Part 2, students should be able to demonstrate an understanding / knowledge of the following:

  • nonclinical pharmacology and toxicology
  • molecular basis of drug actions
  • allometric scaling and dose proportionality assessments based on characteristic PK data
  • defining pharmacodynamic (PD) endpoints and biomarkers
  • differentiating between primary and secondary PK and PD endpoints
  • How to design an early clinical pharmacology developmant plan
  • planning and management of a first-in-man trial
  • principles of data management and information flow
  • principles of reporting and publication
  • principles of medical statistics
  • characteristic issues involved in the development of biologicals and biosimilars

This AGAH course meets the standards for high-quality postgraduate education and training in Medicines Development established by PharmaTrain and has been awarded a PharmaTrain Recognition. The previous courses  were accredited 3 ECTS (Parts I plus II)

Download AGAH_Introductory2026_Programm_Part1.pdf
Download AGAH_Introductory2026_Programm_Part2.pdf
Registration Information

Fees Part I or Part II

1.700 EUR Member*
2.000 EUR Regular Guest

Part I and Part II

2.800 EUR Member*
3.200 EUR Regular Guest

*of AGAH, ACRON, AFPT-CPI, AHPPI, EUFEMED, Healixia, Polfemed

Special fees for students are available on request.
If a company registers four participants, the fifth place is free of charge.

Min. number of participants 10 guests.
Registration deadline Part I: 20 September 2026.

Start your registration:

Online Registration
Additional Information

Day 1     24 November 2026, 09:00–18:30

Day 2     25 November 2026, 09:00–18:00

Day 3     26 November 2026, 09:00–17:45

Day 4     27 November 2026, 09:00–15:00

Mandatory Test (conducted online)

                  1 December 2026, 17:00–19:00

Event Location
Oberursel (Germany)
Event Manager
CSi Hamburg GmbH
+49 40 30770300
agah-meetings@csihamburg.de
https://csihamburg.de
For quick access, insert your search phrase here.

Full commitment for our members

Our office is committed to working for our tasks and our members. You can reach us during normal office hours by phone or, of course, at any time by e-mail.

We will be happy to answer any questions you may have.

The Association for Applied Human Pharmacology (AGAH e.V.)

Association for Applied Human Pharmacology (AGAH)
Arbeitsgemeinschaft für Angewandte Humanpharmakologie e.V.

Sekretariat/Mitgliederverwaltung

Adress: Goernestraße 30
20249 Hamburg

Phone: +49 40 . 30 77 20 97
E-Mail: info@agah.eu
Einstellungen zur Barrierefreiheit

Weitere Informationen zu unseren Maßnahmen zur Verbesserung der Barrierefreiheit finden Sie in der Erklärung zur Barrierefreiheit .